Tofajak 5mg Tablet

Tofajak 5mg Tablet contains Tofacitinib, which is a medication used to treat certain inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It belongs to a class of drugs known as Janus kinase (JAK) inhibitors, which work by blocking the action of specific enzymes involved in the inflammatory process.

Features:

• Anti-inflammatory Action: Tofacitinib inhibits the activity of Janus kinases, which are enzymes involved in the signaling pathways of various cytokines and growth factors responsible for inflammation.
• Disease Modification: Tofajak 5mg Tablet helps reduce joint inflammation and damage in individuals with rheumatoid arthritis and psoriatic arthritis, and it may also induce remission in ulcerative colitis.
• Once-Daily Dosage: It is typically taken once daily, with or without food, as directed by your healthcare provider.

Uses:

• Rheumatoid Arthritis: Tofajak 5mg Tablet is indicated for the treatment of moderate to severe rheumatoid arthritis in adults who have not responded adequately to other disease-modifying antirheumatic drugs (DMARDs).
• Psoriatic Arthritis: It is also used to treat active psoriatic arthritis in adults, either alone or in combination with methotrexate or other nonbiologic DMARDs.
• Ulcerative Colitis: Tofacitinib is prescribed for the induction and maintenance of remission in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response to conventional therapy.

Directions for Use:

• Take one Tofajak 5mg Tablet orally with a full glass of water, with or without food, as directed by your healthcare provider.
• Swallow the tablet whole; do not crush, chew, or break it, as this may affect its controlled-release properties.
• The dosage of Tofacitinib may vary depending on the condition being treated and individual response to therapy.
• Adhere to the prescribed dosage regimen and continue taking the medication as directed, even if you start to feel better.

Precautions:

• Inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking before starting Tofajak 5mg Tablet.
• Tofacitinib may increase the risk of serious infections, including tuberculosis and opportunistic infections. Monitor for signs of infection during treatment and seek medical attention if symptoms occur.
• Regular monitoring of blood counts, liver function, and lipid levels may be necessary during therapy with Tofacitinib.
• Store the tablets in their original packaging, away from heat, moisture, and direct sunlight, and keep them out of reach of children.